首页|CTC、RON及c-Met在早期三阴性乳腺癌预后预测中的作用

CTC、RON及c-Met在早期三阴性乳腺癌预后预测中的作用

扫码查看
目的 分析循环肿瘤细胞(CTC)、受体酪氨酸激酶(RON)及间质表皮转化因子(c-Met)在早期三阴性乳腺癌(TNBC)预后预测中的作用.方法 分析2018年1月至2021年1月于郑州大学第一附属医院进行诊治的1225例乳腺癌患者资料,根据纳入标准最终选取168例TNBC患者设为研究组,选取患者癌旁3 cm的组织为对照组,另选取同时期在本院进行健康体检者168名为健康组.根据患者治疗后的预后情况将研究组分为预后良好组(n=142)以及预后不良组(n=26).比较研究组与健康组CTC的表达情况,比较研究组与对照组c-Met与RON的表达情况,采用多元Logistic回归分析影响TNBC预后的独立危险因素;并通过受试者工作特征曲线(ROC)分析c-Met、RON、CTC对TNBC患者预后的预测价值.结果 研究组CTC水平高于健康组,差异有统计学意义(P<0.05);研究组c-Met与RON阳性表达高于对照组,差异有统计学意义(P<0.05);预后良好组、预后不良组年龄、肿瘤直径比较差异无统计学意义(P>0.05),预后良好组、预后不良组腋窝淋巴结、体重指数、糖尿病、RON、c-Met、CTC比较,差异有统计学意义(P<0.05),经非条件多因素logistic回归模型分析显示,腋窝淋巴结转移、CTC阳性、RON阳性、c-Met阳性为TNBC患者预后的危险因素(P<0.05).CTC、RON及c-Met单独检测以及三者联合检测AUC分别为0.764、0.778、0.776、0.857,其中三者联合检测AUC值最大.结论 联合检测RON、c-MET、CTC水平对TNBC患者预后具有一定的预测价值.
The role of CTC,RON and c-Met in predicting the prognosis of early triple negative breast cancer
Objective To analyze the effects of circulating tumor cells(CTC),receptor tyrosine kinase(RON)and cellular mesenchymal-epithelial transition factor(c-Met)in predicting the prognosis of early triple negative breast cancer(TNBC). Methods The data from 1225 cases of breast cancer diagnosed and treated at the First Affiliated Hospital of Zhengzhou University from January 2018 to January 2021 were ana-lyzed. The study group was divided into a good prognosis group(n=142)and a poor prognosis group(n=26) based on patient outcomes after treatment. The study aims to compare the expression of CTC between the study group and a healthy group,as well as compare the expression of c-Met and RON between the study group and a control group. Multiple logistic regression analysis will be used to identify independent risk factors affecting the prognosis of TNBC. Additionally,the study will analyze the predictive value of c-Met,RON,and CTC on the prognosis of TNBC patients through the receiver operating characteristic curve (ROC) analysis. Results The CTC level in the research group was higher than that in the healthy group ,and the difference was statisti-cally significant(P<0.05). The positive expression of c-Met and RON in the research group was higher than that in the control group,and the difference was statistically significant(P<0.05). There were 142 cases in the good prognosis group and 26 cases in the poor prognosis group,with no difference in age and tumor diameter between patients with different prognoses(P>0.05). However,there were statistically significant differences in axillary lymph nodes,body mass index,diabetes,RON,c-Met,and CTC between the good prognosis group and the poor prognosis group(P<0.05),An unconditional multivariate logistic regression model analy-sis revealed that axillary lymph node metastasis,CTC positivity,RON positivity,and c-Met positivity were risk factors for the prognosis of TNBC patients(P<0.05). The AUCs of CTC,RON and c-Met alone and the combined detection of all three were 0.764,0.778,0.776,and 0.857,respectively,with the highest AUC ob-served for the combined detection of the three. Conclusion The combined detection of RON,c-MET and CTC levels has a certain predictive value for the prognosis of TNBC patients.

CTCRONc-MetTNBC

叶露、张明芳、孙萍、张园园

展开 >

郑州大学第一附属医院乳腺外科,河南,郑州450000

CTC RON c-Met 三阴乳腺癌

河南省医学科技攻关计划联合共建项目

LHGJ20230127

2024

分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
年,卷(期):2024.16(3)
  • 13